BMS at ECCO ’21 Virtual Congress
Showcasing research and commitment to patients in gastroenterology
Intended for U.S. scientific audiences only.
he European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress is an important opportunity to amplify the latest research and breakthroughs for patients with gastrointestinal (GI) immune-mediated diseases.
We are pursuing pathbreaking science and innovative solutions to potentially improve outcomes in GI immune-mediated diseases. Read how our scientists are addressing some of the most challenging diseases of our time, particularly in gastroenterology.
Learn more about our research in IBD through the resources below.